Liposomal nanoparticle essential oil composition for nostril administration
US11166909B1 · kind B1 · utility
0Cited by
5References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 20, 2021 |
| Grant date | Nov 9, 2021 |
| Priority date | — |
| Expiry date | Apr 20, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/46
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention pertains to liposomes containing an oil-in-water emulsion of a selected combination of at least ten different essential plant oils produced with phospholipids found in human membranes and methods for treating respiratory diseases, disorders or conditions by administering the liposomes into the nose and respiratory system.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.